Background: Pharmacogenetic testing for drug-metabolizing enzymes is not yet widely used in clinical practice.
Methods: In an attempt to facilitate the application of this procedure, we have compared two real-time PCR-based methods, the TaqMan and the LightCycler for the pharmacogenetic evaluation of CYP2C9*2/*3 polymorphisms.
Results And Conclusion: Both procedures are suitable for pharmacogenetic studies. The TaqMan procedure was less expensive in terms of cost per sample, but the TaqMan apparatus is more expensive than the LightCycler apparatus.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/CCLM.2006.049 | DOI Listing |
Publication Analysis
Top Keywords
taqman lightcycler
8
pharmacogenetic testing
8
evaluation cyp2c9*2/*3
8
comparison taqman
4
lightcycler systems
4
pharmacogenetic
4
systems pharmacogenetic
4
testing evaluation
4
cyp2c9*2/*3 polymorphisms
4
polymorphisms background
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!